We are live on
!
Find out more
BFG
Bleakley Financial Group Portfolio holdings
AUM
$6.39B
1-Year Est. Return
26.33%
This Fund
S&P 500
This Quarter
Est. Return
+9.25%
1 Year Est. Return
+26.33%
3 Year Est. Return
+77.54%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.45B
AUM Growth
+$308M
(+9.8%)
Cap. Flow
+$63M
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
26.93%
Holding
1,038
New
88
Increased
574
Reduced
310
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$9.87M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$5.76M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$5.14M |
| 4 |
Microsoft
MSFT
|
+$4.64M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$4.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$16.3M |
| 2 |
Vanguard FTSE Pacific ETF
VPL
|
+$15.3M |
| 3 |
iShares Silver Trust
SLV
|
+$9.97M |
| 4 |
UnitedHealth
UNH
|
+$9.03M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$3.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.89% |
| 2 | Healthcare | 11.28% |
| 3 | Financials | 5.65% |
| 4 | Consumer Discretionary | 4.84% |
| 5 | Communication Services | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Theravance Biopharma
TBPH
$874M
| – | – |
-12,584
| Closed | -$141K |
|
1027
Alaunos Therapeutics
TCRT
$4.66M
| – | – |
-95
| Closed | -$1.01K |
|
|
TERN
1028
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-10,452
| Closed | -$67.8K |
|
|
TRUE
1029
DELISTED
TrueCar
TRUE
| – | – |
-14,302
| Closed | -$49.5K |
|
1030
10x Genomics
TXG
$5.97B
| – | – |
-4,189
| Closed | -$234K |
|
|
X
1031
DELISTED
US Steel
X
| – | – |
-4,595
| Closed | -$224K |
|
1032
Yeti Holdings
YETI
$3.85B
| – | – |
-4,652
| Closed | -$241K |
|
|
CTEV
1033
Claritev Corp
CTEV
$414M
| – | – |
-450
| Closed | -$25.9K |
|
|
MMAT
1034
DELISTED
Meta Materials Inc. Common Stock
MMAT
| – | – |
-512
| Closed | -$3.38K |
|
|
SPLK
1035
DELISTED
Splunk Inc
SPLK
| – | – |
-1,667
| Closed | -$254K |
|
|
SOVO
1036
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| – | – |
-29,961
| Closed | -$660K |
|
|
CRGE
1037
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| – | – |
-20,555
| Closed | -$2.35K |
|
|
CHIC
1038
DELISTED
Global X MSCI China Communication Services ETF
CHIC
| – | – |
-15,649
| Closed | -$208K |
|
Similar funds
PCH
GT
EWM
BFS
EC
HI
OMC
TCM
Bleakley Financial Group's Q1 2024 Portfolio in Review
As of Q1 2024, Bleakley Financial Group held 1,038 positions worth $3.45B, up 9.8% from $3.15B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Bleakley Financial Group's Q1 2024 filing shows 88 new, 574 increased, 310 reduced and 43 closed positions. Its largest new stake was Manchester United: 228,887 shares worth $3.2M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $16.3M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- Bleakley Financial Group's largest Q1 2024 buy was Manchester United: 228,887 shares worth $3.2M.
- Bleakley Financial Group added most to Elevance Health in Q1 2024, an estimated $9.87M increase.
- Bleakley Financial Group's biggest Q1 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $16.3M.
- Bleakley Financial Group fully exited iShares China Large-Cap ETF in Q1 2024, selling an estimated $3.94M.
- Bleakley Financial Group's ten largest holdings make up 27% of its $3.45B portfolio in Q1 2024.
- Bleakley Financial Group opened 88 new positions and closed 43 in Q1 2024.
- Bleakley Financial Group's portfolio value rose 9.8% quarter-over-quarter to $3.45B.
Based on Bleakley Financial Group's 13F filing for Q1 2024, filed 8 May 2024.